Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

1.

Genesis of EDCTP2.

Zumla A, Makanga M, Nyirenda T, Beattie P, Olesen OF, Breugelmans JG, Aklillu E, Corrah T, Mgone C.

Lancet Infect Dis. 2015 Jan;15(1):11-3. doi: 10.1016/S1473-3099(14)71034-5. Epub 2014 Dec 2. No abstract available.

PMID:
25477021
2.

Calling on Europe to support operational research in low-income and middle-income countries.

Quaglio G, Ramsay A, Harries AD, Karapiperis T, Putoto G, Dye C, Olesen OF, Tomson G, Zachariah R.

Lancet Glob Health. 2014 Jun;2(6):e308-10. doi: 10.1016/S2214-109X(14)70218-9. Epub 2014 May 21. No abstract available.

3.

List-mode PET motion correction using markerless head tracking: proof-of-concept with scans of human subject.

Olesen OV, Sullivan JM, Mulnix T, Paulsen RR, Højgaard L, Roed B, Carson RE, Morris ED, Larsen R.

IEEE Trans Med Imaging. 2013 Feb;32(2):200-9. doi: 10.1109/TMI.2012.2219693. Epub 2012 Sep 19.

PMID:
23008249
4.

Analysis of pan-African Centres of excellence in health innovation highlights opportunities and challenges for local innovation and financing in the continent.

Nwaka S, Ochem A, Besson D, Ramirez B, Fakorede F, Botros S, Inyang U, Mgone C, Adae-Mensah I, Konde V, Nyasse B, Okole B, Guantai A, Loots G, Atadja P, Ndumbe P, Sanou I, Olesen O, Ridley R, Ilunga T.

BMC Int Health Hum Rights. 2012 Jul 27;12:11. doi: 10.1186/1472-698X-12-11.

5.

Health research in Africa: getting priorities right.

Olesen OF, Parker MI.

Trop Med Int Health. 2012 Sep;17(9):1048-52. doi: 10.1111/j.1365-3156.2012.03027.x. Epub 2012 Jun 21. No abstract available.

6.

Methods for motion correction evaluation using 18F-FDG human brain scans on a high-resolution PET scanner.

Keller SH, Sibomana M, Olesen OV, Svarer C, Holm S, Andersen FL, Højgaard L.

J Nucl Med. 2012 Mar;53(3):495-504. doi: 10.2967/jnumed.111.095240. Epub 2012 Feb 13.

7.

The selection of experts evaluating health projects for the EU Sixth Framework Program.

Quaglio G, Guardabasso V, Olesen OF, Draghia-Akli R.

Z Gesundh Wiss. 2011 Oct;19(5):445-452. Epub 2011 Feb 8.

8.

Motion tracking for medical imaging: a nonvisible structured light tracking approach.

Olesen OV, Paulsen RR, Højgaard L, Roed B, Larsen R.

IEEE Trans Med Imaging. 2012 Jan;31(1):79-87. doi: 10.1109/TMI.2011.2165157. Epub 2011 Aug 18.

PMID:
21859614
9.

Research and capacity building for control of neglected tropical diseases: the need for a different approach.

Kariuki T, Phillips R, Njenga S, Olesen OF, Klatser PR, Porro R, Lock S, Cabral MH, Gliber M, Hanne D.

PLoS Negl Trop Dis. 2011;5(5):e1020. doi: 10.1371/journal.pntd.0001020. Epub 2011 May 31. No abstract available.

10.

European Union vaccine research--an overview.

Sautter J, Olesen OF, Bray J, Draghia-Akli R.

Vaccine. 2011 Sep 9;29(39):6723-7. doi: 10.1016/j.vaccine.2010.12.060. Epub 2010 Dec 31.

PMID:
21195799
11.

Research priorities for neglected infectious diseases in Latin America and the Caribbean region.

Dujardin JC, Herrera S, do Rosario V, Arevalo J, Boelaert M, Carrasco HJ, Correa-Oliveira R, Garcia L, Gotuzzo E, Gyorkos TW, Kalergis AM, Kouri G, Larraga V, Lutumba P, Macias Garcia MA, Manrique-Saide PC, Modabber F, Nieto A, Pluschke G, Robello C, Rojas de Arias A, Rumbo M, Santos Preciado JI, Sundar S, Torres J, Torrico F, Van der Stuyft P, Victoir K, Olesen OF.

PLoS Negl Trop Dis. 2010 Oct 26;4(10):e780. doi: 10.1371/journal.pntd.0000780. Review. No abstract available.

12.

Motion tracking in narrow spaces: a structured light approach.

Olesen OV, Paulsen RR, Højgaar L, Roed B, Larsen R.

Med Image Comput Comput Assist Interv. 2010;13(Pt 3):253-60.

PMID:
20879407
13.

Collaborative actions in anti-trypanosomatid chemotherapy with partners from disease endemic areas.

Dujardin JC, González-Pacanowska D, Croft SL, Olesen OF, Späth GF.

Trends Parasitol. 2010 Aug;26(8):395-403. doi: 10.1016/j.pt.2010.04.012. Epub 2010 Jun 9. Review.

PMID:
20538522
14.

Biomarkers for tuberculosis disease activity, cure, and relapse.

Wallis RS, Wang C, Doherty TM, Onyebujoh P, Vahedi M, Laang H, Olesen O, Parida S, Zumla A.

Lancet Infect Dis. 2010 Feb;10(2):68-9. doi: 10.1016/S1473-3099(10)70003-7. No abstract available.

PMID:
20113972
15.

Tuberculosis research in the European union: past achievements and future challenges.

Lång H, Quaglio G, Olesen OF.

Tuberculosis (Edinb). 2010 Jan;90(1):1-6. doi: 10.1016/j.tube.2009.10.002. Epub 2009 Oct 31.

PMID:
19880350
16.

Perspectives for parasitology and parasitology networks in Europe.

Dupouy-Camet J, Olesen OF, Dei-Cas E, Loiseau PM, Mas-Coma S.

Trends Parasitol. 2009 Jul;25(7):293-5. doi: 10.1016/j.pt.2009.03.010. Epub 2009 Jun 17.

PMID:
19540165
17.

European Union conference on poverty-related diseases research.

Gryseels B, Zumla A, Troye-Blomberg M, Kieny MP, Quaglio G, Holtel A, Laang H, Romaris M, De Magistris MT, Nuez AN, Olesen OF, Ghalouci R, Lönnroth A.

Lancet Infect Dis. 2009 Jun;9(6):334-7. doi: 10.1016/S1473-3099(09)70129-X. No abstract available.

PMID:
19467472
18.

The European effort towards the development of mucosal vaccines for poverty-related diseases.

Medaglini D, Olesen OF, Rappuoli R.

Vaccine. 2009 May 5;27(20):2641-8. doi: 10.1016/j.vaccine.2009.02.070. Epub 2009 Mar 3. Review.

PMID:
19428873
19.

Vaccine adjuvants: scientific challenges and strategic initiatives.

Harandi AM, Davies G, Olesen OF.

Expert Rev Vaccines. 2009 Mar;8(3):293-8. doi: 10.1586/14760584.8.3.293. Review.

PMID:
19249971
20.

Biomarkers for tuberculosis disease activity, cure, and relapse.

Wallis RS, Doherty TM, Onyebujoh P, Vahedi M, Laang H, Olesen O, Parida S, Zumla A.

Lancet Infect Dis. 2009 Mar;9(3):162-72. doi: 10.1016/S1473-3099(09)70042-8. Review.

PMID:
19246020
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk